Shiv Sena MPs meet on trust vote put off
A crucial meeting of Shiv Sena MPs, scheduled to be held in Mumbai shortly after noon to discus the party's strategy for the July 22 trust vote in Lok Sabha, has been postponed, party sources said.
The meeting is now likely to be held at around 8 pm on Saturday, the sources said, adding Sena Executive President Uddhav Thackeray would `guide' the party MPs.
Uddhav has already announced that Sena, which supported UPA nominee Pratibha Patil in last year's Presidential poll on the issue of `Marathi pride', would back BJP-led NDA during the trust vote.
Enter your email to get our daily newsletter in your inbox
- For the first time, TMC’s youth unit president and chief minister Mamata Banerjee’s nephew Abhishek Banerjee stepped in to solve the crisis. He sent party spokesperson Kunal Ghosh to bring Roy to his office on Camac Street in south Kolkata and held a two-hour meeting on Friday.
- To meet Shah’s target of winning more than 200 of Bengal’s 294 assembly seats in 2021, the BJP has put together its biggest election machinery in the eastern state.
- More than 12,000 doses of the vaccine have reached Ladakh of which around 4,000 have been earmarked for armed forces personnel to protect them from Covid-19, the officials said speaking on condition of anonymity.
- MPW workers demand promotion and cadre-restructuring.
- Choudhury's comments came after the TMC had on Wednesday said the Congress and the Left should support Banerjee in her fight against the BJP, a suggestion rejected by the two parties.
- In view of high active caseload the state had sought more vials in the first stage but it was told that in the second stage more vials will be given. Once lauded for its Covid-19 management, now Kerala is the virus hotspot of the country.
- The two countries will also work together in the field of telecom security, submarine optical fibre cable system to islands of India.
- Nepal is looking to India to provide vaccines as grant assistance for the first phase of its vaccination programme, which requires 12 million doses to cover 20% of its population. Nepal also plans to buy millions of doses from foreign suppliers, including SII and Bharat Biotech.